People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Hyperkalemia is a potentially serious condition that may be associated with numerous pathophysiological conditions. Clinically significant hyperkalemia reduces membrane excitability and disturbs ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...

Other than having high blood pressure, I am healthy, eat a Mediterranean-style diet, and exercise most days. Since 2021, I have been taking one tab of amlodipine/valsartan daily with blood pressure ...

(PV) treatment approaches include both therapeutic phlebotomy and medications like hydroxyurea or interferon to control blood counts, with treatment selection based on individual risk factors and ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...